{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:37:40Z","timestamp":1785465460938,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00381-024-06730-z","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T13:50:34Z","timestamp":1735307434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pediatric diffuse intrinsic pontine gliomas- a prospective observational study from a tertiary care neurosurgical center"],"prefix":"10.1007","volume":"41","author":[{"given":"Aprajita","family":"Chaturvedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishanth","family":"Sadashiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathyarao","family":"Kalahasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhas","family":"Konar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhuraj","family":"AR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Beniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur","family":"Pruthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arivazhagan","family":"Arimappamagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vani","family":"Santosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"issue":"12 Suppl 2","key":"6730_CR1","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014\u20132018. Neuro-Oncol. 23(12 Suppl 2):iii1\u2013iii105. https:\/\/doi.org\/10.1093\/neuonc\/noab200","journal-title":"Neuro-Oncol."},{"issue":"17","key":"6730_CR2","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1093\/jnci\/90.17.1269","volume":"90","author":"MA Smith","year":"1998","unstructured":"Smith MA, Freidlin B, Ries LA, Simon R (1998) Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 90(17):1269\u20131277. https:\/\/doi.org\/10.1093\/jnci\/90.17.1269","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 5","key":"6730_CR3","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT et al (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro-Oncol 21(Suppl 5):v1\u2013v100. https:\/\/doi.org\/10.1093\/neuonc\/noz150","journal-title":"Neuro-Oncol"},{"issue":"6","key":"6730_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/neuonc\/noaa295","volume":"23","author":"N Patil","year":"2021","unstructured":"Patil N et al (2021) Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000\u20132017. Neuro-Oncol 23(6):990\u2013998. https:\/\/doi.org\/10.1093\/neuonc\/noaa295","journal-title":"Neuro-Oncol"},{"issue":"12","key":"6730_CR5","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/neuonc\/noac123","volume":"24","author":"AL Bartlett","year":"2022","unstructured":"Bartlett AL et al (2022) Characteristics of children \u226436 months of age with DIPG: a report from the international DIPG registry. Neuro-Oncol 24(12):2190\u20132199. https:\/\/doi.org\/10.1093\/neuonc\/noac123","journal-title":"Neuro-Oncol"},{"issue":"3","key":"6730_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"D-A Khuong-Quang","year":"2012","unstructured":"Khuong-Quang D-A et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol (Berl) 124(3):439\u2013447. https:\/\/doi.org\/10.1007\/s00401-012-0998-0","journal-title":"Acta Neuropathol (Berl)"},{"issue":"6","key":"6730_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","volume":"130","author":"D Castel","year":"2015","unstructured":"Castel D et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol (Berl) 130(6):815\u2013827. https:\/\/doi.org\/10.1007\/s00401-015-1478-0","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"6730_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000120511","volume":"16","author":"AJ Barkovich","year":"2008","unstructured":"Barkovich AJ et al (2008) Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg 16(2):73\u201383. https:\/\/doi.org\/10.1159\/000120511","journal-title":"Pediatr Neurosurg"},{"issue":"1","key":"6730_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40478-020-00930-9","volume":"8","author":"J Chiang","year":"2020","unstructured":"Chiang J et al (2020) Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG. Acta Neuropathol Commun 8(1):57. https:\/\/doi.org\/10.1186\/s40478-020-00930-9","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"6730_CR10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1177\/0883073816634855","volume":"31","author":"J Tisnado","year":"2016","unstructured":"Tisnado J, Young R, Peck KK, Haque S (2016) Conventional and advanced imaging of diffuse intrinsic pontine glioma. J Child Neurol 31(12):1386. https:\/\/doi.org\/10.1177\/0883073816634855","journal-title":"J Child Neurol"},{"issue":"5","key":"6730_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/neuonc\/noab245","volume":"24","author":"MA Lazow","year":"2021","unstructured":"Lazow MA et al (2021) Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG registry. Neuro-Oncol 24(5):821. https:\/\/doi.org\/10.1093\/neuonc\/noab245","journal-title":"Neuro-Oncol"},{"issue":"4","key":"6730_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A et al (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(4):520-537.e5. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.017","journal-title":"Cancer Cell"},{"key":"6730_CR13","unstructured":"International DIPG\/DMG Registry. Accessed: Apr. 06, 2024. [Online]. Available: https:\/\/www.dipgregistry.org\/"},{"issue":"1","key":"6730_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/neuonc\/noab140","volume":"24","author":"C Erker","year":"2022","unstructured":"Erker C et al (2022) Characteristics of patients \u226510 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG\/DMG registry. Neuro-Oncol 24(1):141\u2013152. https:\/\/doi.org\/10.1093\/neuonc\/noab140","journal-title":"Neuro-Oncol"},{"issue":"19","key":"6730_CR15","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","volume":"36","author":"LM Hoffman","year":"2018","unstructured":"Hoffman LM et al (2018) Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the international and European society for pediatric oncology DIPG registries. J Clin Oncol 36(19):1963\u20131972. https:\/\/doi.org\/10.1200\/JCO.2017.75.9308","journal-title":"J Clin Oncol"},{"issue":"4","key":"6730_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10555-019-09824-2","volume":"38","author":"WM Rashed","year":"2019","unstructured":"Rashed WM, Maher E, Adel M, Saber O, Zaghloul MS (2019) Pediatric diffuse intrinsic pontine glioma: where do we stand? Cancer Metastasis Rev 38(4):759\u2013770. https:\/\/doi.org\/10.1007\/s10555-019-09824-2","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"6730_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/1570159x14666160509123229","volume":"15","author":"TB Johung","year":"2017","unstructured":"Johung TB, Monje M (2017) Diffuse intrinsic pontine glioma: new pathophysiological insights and emerging therapeutic targets. Curr Neuropharmacol 15(1):88\u201397. https:\/\/doi.org\/10.2174\/1570159x14666160509123229","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"6730_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4103\/0028-3886.344673","volume":"70","author":"S Kandregula","year":"2022","unstructured":"Kandregula S et al (2022) Diffuse intrinsic pontine gliomas in adults: a retrospective study. Neurol India 70(2):584. https:\/\/doi.org\/10.4103\/0028-3886.344673","journal-title":"Neurol India"},{"issue":"11","key":"6730_CR19","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/neuonc\/noaa140","volume":"22","author":"JL Leach","year":"2020","unstructured":"Leach JL et al (2020) MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the international DIPG registry. Neuro-Oncol 22(11):1647\u20131657. https:\/\/doi.org\/10.1093\/neuonc\/noaa140","journal-title":"Neuro-Oncol"},{"issue":"1","key":"6730_CR20","doi-asserted-by":"publisher","first-page":"vdab042","DOI":"10.1093\/noajnl\/vdab042","volume":"3","author":"LT Tam","year":"2021","unstructured":"Tam LT et al (2021) MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study. Neuro-Oncol Adv 3(1):vdab042. https:\/\/doi.org\/10.1093\/noajnl\/vdab042","journal-title":"Neuro-Oncol Adv"},{"issue":"4","key":"6730_CR21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/neuonc\/nos330","volume":"15","author":"DA Walker","year":"2013","unstructured":"Walker DA et al (2013) A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method. Neuro-Oncol 15(4):462\u2013468. https:\/\/doi.org\/10.1093\/neuonc\/nos330","journal-title":"Neuro-Oncol"},{"key":"6730_CR22","doi-asserted-by":"publisher","unstructured":"Kickingereder P, Willeit P, Simon T, Ruge MI (2013) Diagnostic value and safety of stereotactic biopsy for brainstem tumors: a systematic review and meta-analysis of 1480 cases. Neurosurgery 72(6):873\u2013881. https:\/\/doi.org\/10.1227\/NEU.0b013e31828bf445. (discussion 882; quiz 882)","DOI":"10.1227\/NEU.0b013e31828bf445"},{"issue":"4","key":"6730_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00401-014-1319-6","volume":"128","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz P, Bartels U, Bouffet E, Becher O, Hawkins C (2014) Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathol (Berl) 128(4):573\u2013581. https:\/\/doi.org\/10.1007\/s00401-014-1319-6","journal-title":"Acta Neuropathol (Berl)"},{"key":"6730_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fonc.2015.00147","volume":"5","author":"P Buczkowicz","year":"2023","unstructured":"Buczkowicz P, Hawkins C (2023) Pathology, molecular genetics, and epigenetics of diffuse intrinsic pontine glioma. Front Oncol 5:147. https:\/\/doi.org\/10.3389\/fonc.2015.00147","journal-title":"Front Oncol"},{"issue":"22","key":"6730_CR25","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.1158\/1078-0432.CCR-19-0126","volume":"25","author":"C Werbrouck","year":"2019","unstructured":"Werbrouck C et al (2019) TP53 pathway alterations drive radioresistance in diffuse intrinsic pontine gliomas (DIPG). Clin Cancer Res Off J Am Assoc Cancer Res 25(22):6788\u20136800. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0126","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"6730_CR26","doi-asserted-by":"publisher","unstructured":"Vuong HG, Le HT, Jea A, McNall-Knapp R, Dunn IF (2022) Risk stratification of H3 K27M-mutant diffuse midline gliomas based on anatomical locations: an integrated systematic review of individual participant data. J Neurosurg. Pediatr 1\u20138. https:\/\/doi.org\/10.3171\/2022.3.PEDS2250","DOI":"10.3171\/2022.3.PEDS2250"},{"issue":"21","key":"6730_CR27","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.3390\/cancers13215280","volume":"13","author":"DP Argersinger","year":"2021","unstructured":"Argersinger DP, Rivas SR, Shah AH, Jackson S, Heiss JD (2021) New developments in the pathogenesis, therapeutic targeting, and treatment of H3K27M-mutant diffuse midline glioma. Cancers 13(21):5280. https:\/\/doi.org\/10.3390\/cancers13215280","journal-title":"Cancers"},{"issue":"1","key":"6730_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF00263825","volume":"7","author":"IA Langmoen","year":"1991","unstructured":"Langmoen IA, Lundar T, Storm-Mathisen I, Lie SO, Hovind KH (1991) Management of pediatric pontine gliomas. Childs Nerv Syst 7(1):13\u201315. https:\/\/doi.org\/10.1007\/BF00263825","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"6730_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijrobp.2012.04.006","volume":"85","author":"GO Janssens","year":"2013","unstructured":"Janssens GO et al (2013) Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis. Int J Radiat Oncol Biol Phys 85(2):315\u2013320. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.04.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"6730_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.adro.2019.03.009","volume":"4","author":"M Gallitto","year":"2019","unstructured":"Gallitto M et al (2019) Role of radiation therapy in the management of diffuse intrinsic pontine glioma: a systematic review. Adv Radiat Oncol 4(3):520\u2013531. https:\/\/doi.org\/10.1016\/j.adro.2019.03.009","journal-title":"Adv Radiat Oncol"},{"key":"6730_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2019.03.003","volume":"114","author":"GO Janssens","year":"2019","unstructured":"Janssens GO et al (2019) Recommendations for the organisation of care in paediatric radiation oncology across Europe: a SIOPE\u2013ESTRO\u2013PROS\u2013CCI-Europe collaborative project in the framework of the JARC. Eur J Cancer 114:47\u201354. https:\/\/doi.org\/10.1016\/j.ejca.2019.03.003","journal-title":"Eur J Cancer"},{"issue":"1","key":"6730_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11060-019-03340-7","volume":"146","author":"Y Izzuddeen","year":"2020","unstructured":"Izzuddeen Y, Gupta S, Haresh KP, Sharma D, Giridhar P, Rath GK (2020) Hypofractionated radiotherapy with temozolomide in diffuse intrinsic pontine gliomas: a randomized controlled trial. J Neurooncol 146(1):91\u201395. https:\/\/doi.org\/10.1007\/s11060-019-03340-7","journal-title":"J Neurooncol"},{"issue":"1","key":"6730_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijrobp.2009.04.031","volume":"77","author":"R Jalali","year":"2010","unstructured":"Jalali R et al (2010) Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 77(1):113\u2013118. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.031","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6730_CR34","doi-asserted-by":"publisher","first-page":"1973947814Y0000","DOI":"10.1179\/1973947814Y.0000000228","volume":"27","author":"D Rizzo","year":"2014","unstructured":"Rizzo D et al (2014) Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise? J. Chemother. Florence Italy 27:1973947814Y0000000228. https:\/\/doi.org\/10.1179\/1973947814Y.0000000228","journal-title":"J. Chemother. Florence Italy"},{"issue":"14","key":"6730_CR35","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1158\/0008-5472.CAN-23-0186","volume":"83","author":"ER Jackson","year":"2023","unstructured":"Jackson ER et al (2023) ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma. Cancer Res 83(14):2421\u20132437. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0186","journal-title":"Cancer Res"},{"issue":"1","key":"6730_CR36","doi-asserted-by":"publisher","first-page":"vdac143","DOI":"10.1093\/noajnl\/vdac143","volume":"4","author":"SL Gardner","year":"2022","unstructured":"Gardner SL et al (2022) Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. Neuro-Oncol Adv 4(1):vdac143. https:\/\/doi.org\/10.1093\/noajnl\/vdac143","journal-title":"Neuro-Oncol Adv"},{"issue":"16_suppl","key":"6730_CR37","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS2082","volume":"40","author":"Y Odia","year":"2022","unstructured":"Odia Y et al (2022) Window-of-opportunity study of ONC201 in pediatric patients with diffuse intrinsic pontine glioma (DIPG) and thalamic glioma. J. Clin. Oncol. 40(16_suppl):2082\u20132082. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.TPS2082","journal-title":"J. Clin. Oncol."}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-024-06730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-024-06730-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-024-06730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:15:56Z","timestamp":1770815756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-024-06730-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["6730"],"URL":"https:\/\/doi.org\/10.1007\/s00381-024-06730-z","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was taken from all the patients included in the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Institute Ethics Committee approval was taken before the commencement of the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"71"}}